Metraipolis › archive › dc_9dcc2a799eeb
TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy — Europe PMC PMID:40888912
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40888912
- DOI
- 10.1007/s00345-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:59:40.021Z
- SHA-256 of the archived text
3c31762888d82e2b40a84f6c521c66de5abaca0b78a3e59d27e3ed770fa26cc0- Stable URL of this page
https://metraipolis.com/documento/dc_9dcc2a799eeb
How to cite
TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy — Europe PMC PMID:40888912 — Europe PMC (en), https://europepmc.org/article/MED/40888912 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9dcc2a799eeb (Metraipolis archive dc_9dcc2a799eeb, sha256 3c31762888d82e2b40a84f6c521c66de5abaca0b78a3e59d27e3ed770fa26cc0)
BibTeX
@misc{dc9dcc2a799eeb,
title = {TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy — Europe PMC PMID:40888912},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40888912},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9dcc2a799eeb; sha256 3c31762888d82e2b40a84f6c521c66de5abaca0b78a3e59d27e3ed770fa26cc0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40888912. Agents can read the archived copy with the MCP tool read_document.